University Of California, Davis Establishes Institute For Psychedelics For Mental Health Conditions

The University of California, Davis (UC Davis) has launched the Institute for Psychedelics and Neurotherapeutics to advance basic knowledge about the mechanisms of psychedelics. The goal is to translate this knowledge into safe and effective treatments for diseases such as depression, post-traumatic stress disorder, addiction, Alzheimer’s disease, and Parkinson’s disease, among others. The new institute will bring together scientists across a range of disciplines and partner with the pharmaceutical industry to ensure that key discoveries lead to new medicines for consumers. A unique feature of the UC Davis institute will be its focus on chemistry and the . . .